Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 674 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 674 shares of the business’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $31.44, for a total value of $21,190.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

USANA Health Sciences Trading Up 1.2 %

NYSE:USNA traded up $0.38 during mid-day trading on Monday, reaching $33.34. The company’s stock had a trading volume of 68,708 shares, compared to its average volume of 173,767. The firm’s fifty day moving average price is $32.96 and its two-hundred day moving average price is $36.18. The stock has a market cap of $635.46 million, a P/E ratio of 11.78, a PEG ratio of 0.93 and a beta of 0.98. USANA Health Sciences, Inc. has a 12-month low of $27.71 and a 12-month high of $50.32.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. Analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on USNA shares. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. DA Davidson decreased their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday, February 27th. Finally, Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

Hedge Funds Weigh In On USANA Health Sciences

Several hedge funds and other institutional investors have recently modified their holdings of USNA. Barclays PLC increased its position in USANA Health Sciences by 111.9% during the third quarter. Barclays PLC now owns 27,737 shares of the company’s stock valued at $1,052,000 after acquiring an additional 14,647 shares during the last quarter. Rhumbline Advisers grew its stake in shares of USANA Health Sciences by 39.8% during the 4th quarter. Rhumbline Advisers now owns 49,390 shares of the company’s stock valued at $1,773,000 after purchasing an additional 14,068 shares during the period. Geode Capital Management LLC increased its position in shares of USANA Health Sciences by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after purchasing an additional 12,898 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of USANA Health Sciences by 2.8% in the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company’s stock worth $1,924,000 after purchasing an additional 1,480 shares during the period. Finally, State Street Corp boosted its holdings in shares of USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after buying an additional 2,782 shares during the last quarter. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.